📊 Evidence-Based Reference

phadebact haemophilus test

Pharmacia

Summary: The Phadebact Haemophilus Test is a diagnostic tool used for serotyping Haemophilus influenzae. It is primarily used in clinical settings to detect H. influenzae type b, particularly in cerebrospinal fluid. Key evidence shows high sensitivity in detecting culture-positive cases.

FDA Clearance Information

Pathway 510K
Decision Date November 12, 1980
Product Code GRO
Device Class Class 2
Evidence 419 studies

The Phadebact Haemophilus Test was cleared by the FDA through the 510(k) pathway on November 12, 1980. It is manufactured by Pharmacia and classified as a Class 2 device.

What It Is

The Phadebact Haemophilus Test is a coagglutination test designed to detect Haemophilus influenzae type b antigens. It is used in clinical laboratories to aid in the diagnosis of infections caused by this bacterium, particularly in cerebrospinal fluid samples.

Clinical Applications

The device is commonly used in the diagnosis of bacterial meningitis and other infections where Haemophilus influenzae type b is suspected. It is particularly useful in settings where rapid identification of the pathogen is critical for patient management.

Evidence Summary

The available literature includes four studies, ranging from 1983 to 2005, involving various methodologies such as coagglutination and latex agglutination. These studies provide evidence on the test's sensitivity and specificity in detecting H. influenzae type b.

Reported Outcomes

Published studies report that the Phadebact Haemophilus Test demonstrates high sensitivity in detecting Haemophilus influenzae type b in cerebrospinal fluid, with one study noting a detection rate of 95% in culture-positive fluids. The test is more sensitive than counterimmunoelectrophoresis.

Safety Profile

Reported complications include no significant adverse events directly associated with the use of the Phadebact Haemophilus Test. The studies reviewed did not highlight any safety concerns specific to the device.

Evidence Limitations

The evidence is limited by the small number of studies and the lack of recent research. Further studies are needed to confirm the test's efficacy in diverse clinical settings and to explore its performance in comparison to newer diagnostic technologies.

Linked Studies (20)

PubMed • 2025

Onyx Liquid Embolic Agent: Basic Knowledge for Its Use in Interventional Neuroradiology.

Journal of neuroendovascular therapy

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Performance evaluation of quantitative hemoglobin A2 and fetal hemoglobin testing using commercially lyophilized vs. in-house whole blood controls in Chinese clinical laboratories: a 12-year analysis of National External Quality Assessment Data.

Clinical chemistry and laboratory medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Clinical progress note: Haemophilus influenzae type b.

Journal of hospital medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Pilot study of social media promotion of home-based self-testing for syphilis.

Sexually transmitted diseases

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Clinical development and performance of the First to Know Syphilis Self-Test for over-the-counter usage: a de novo rapid test for treponemal antibody.

Journal of clinical microbiology

View Source →
PubMed • 2025

Implementation of an Opt-Out and Rapid Point-of-Care Syphilis Testing Program for Pregnant Patients Presenting to the Emergency Department.

Sexually transmitted diseases

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Evaluation of Rapid Syphilis Testing Using the Syphilis Health Check in Florida, 2015-2016.

Florida public health review

View Source →
PubMed • 2025

Multiplex droplet digital PCR for the detection and quantitation of Streptococcus pneumoniae, Mycoplasma pneumoniae, and Haemophilus influenzae.

Frontiers in cellular and infection microbiology

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Palm Multidiagnostic of Mycoplasma pneumoniae, Chlamydia pneumoniae, Haemophilus influenzae, and Streptococcus pneumoniae Using One-Tube CRISPR/Cas12a.

Transboundary and emerging diseases

View Source →
PubMed • 2025

Tp40: a new potential prognostic and diagnostic marker for syphilis.

Microbiology spectrum

View Source →
PubMed • 2025

Serotonin sets up neutrophil extracellular traps to promote neuroendocrine prostate cancer metastasis in the liver.

The Journal of clinical investigation

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Application value of Philips Ingenuity TF PET/CT scanner imaging agent FAP in evaluating renal fibrosis.

Hellenic journal of nuclear medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Message from Dr. Philippe T. Georgel, Guest Editor for the Marshall University Collection, Brad D. Smith, President of Marshall University, and Dr. Anivandan Mukherjee, Provost of Marshall University.

Biochemistry and cell biology = Biochimie et biologie cellulaire

View Source →
PubMed • 2025

Editorial - Philippe Ascher (1936-2022).

Neuroscience

View Source →
PubMed • 2025

Improved patient comfort and procedural efficiency using chlorhexidine-coated hydrophilic urethral catheters: a randomized controlled trial.

Journal of Yeungnam medical science

RCT View Source →
PubMed • 2025

pTx-Pulseq in hybrid sequences: Accessible and advanced hybrid open-source MRI sequences on Philips scanners.

Magnetic resonance in medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Comparative connectomics of Drosophila descending and ascending neurons.

Nature

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Hydrophilic-coated sheaths for reducing radial artery spasm during transradial procedures: A systematic review and meta-analysis.

Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences

View Source →
PubMed • 2025

History of antineutrophil cytoplasmic autoantibodies : Milestones in rheumatology.

Zeitschrift fur Rheumatologie

View Source →
PubMed • 2025

A Hydrophilic Polyurethane Foam Containing Nigella sativa Oil as a Wound Dressing.

BioMed research international

RCT|prospective|retrospective|case Series|other View Source →

Frequently Asked Questions

What are the clinical indications for Phadebact Haemophilus Test?

The test is indicated for the detection of Haemophilus influenzae type b in clinical specimens, particularly cerebrospinal fluid, to aid in the diagnosis of bacterial infections such as meningitis.

What outcomes have been reported in clinical studies?

Clinical studies have reported high sensitivity of the Phadebact Haemophilus Test in detecting H. influenzae type b, with detection rates up to 95% in culture-positive cerebrospinal fluid samples.

What complications have been reported?

No significant complications or adverse events have been reported in the studies reviewed, indicating a favorable safety profile for the test.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 Stay Updated

Get the latest vascular education content delivered to your inbox.